Brighter AB (publ)

Brighter wins order worth €2.5 million.

Pressmeddelande   •   Nov 30, 2011 07:36 CET

Rubin Medical has placed an initial order of 5000pcs Brighter One ™ for the Scandinavian market.

By placing the order now Rubin Medical have secured their initial stock of Brighter One ™ for the launch, which is scheduled to late 2012.

"We are really eager to start promoting Brighter One in Scandinavia," says Mikael Cederhag, founder and owner of Rubin Medical

The value of the order comes not only from the device Brighter One ™, but also blood glucose tests for it. An average user of a Brighter One ™ uses between 2-15 blood glucose tests a day. A conservative forecast estimates the order to generate revenues of at least €2.5 million over a period of just over 24 months.

"I am truly pleased to have the first order in place and I can barely wait to ship it out as quickly as possible. Just with this order secured, we know that we are in the clear." says Truls Sjöstedt CEO

In the Nordic region, there are about 1.5 million diabetics and almost 500,000 is estimated to be insulin-treated. The forecast for the number of users of Brighter One ™ solely on the Nordic markets is estimated to an additional 25 000 users for the first two years.

For more information please visit:

www.BrighterCompany.com/english

Please also be advised that all Swedish material will not be translated and that the partial translations made available are to be viewed as an introduction to the Swedish offer. For the complete offer we herby refer you to the Swedish material.

About Brighter AB (publ)

Brighter One - the patented all-in-one device that replaces the five things millions of people with diabetes need to use multiple times every day to survive and feel well.

Brighter develops and commercializes innovative solutions for diabetes self-care. It is a STING Alumni company. Financing has come from governmental and institutional investors such as ALMI, Innovationsbron, KAS Innovationsfond (a Bonnier family foundation) as well as from private investors.

Until December 15, there is a unique opportunity to buy shares in Brighter. After the introduction issuing, Brighter will be listed at AktieTorget (www.aktietorget.se). Brighter reserves the right to close the issue as soon as it is fully subscribed.

Five Good Reasons to Invest in Brighter

  • 75 per cent of all insulin-treated diabetics want an integrated device for self-care. No player has so far offered diabetics such an all-in-one solution.
  • Brighter has developed and been granted patent for the world’s first all-in-one self-care solution for diabetics that does not need to be attached to the body. The primary target group for this product series, Brighter One™, consists of 14 million diabetics in Europe and USA – a market with an annual turnover of approximately €2.5 billion and that grows by 5-10% per year.
  • The critical technical components are licensed in and already included in both FDA-approved and CE-marked products. Brighter has attained a technical “proof of concept” and carried out a detailed cost assessment for parts and production.
  • Brighter is ready for production adaption and with the on-going IPO, the production of the manufacturing line is assured.
  • Sales channels are ready for the Scandinavian markets thanks to cooperation with Rubin Medical – one of the largest distributors of diabetes devices in the Scandinavian markets as well as for the last two years twice appointed Gazelle company by Dagens Industri, Sweden’s leading daily financial newspaper.

 

Disclaimer

Due to the regulations of respective countries, if you reside in the USA, Canada, Australia, Japan or New Zealand you may NOT take part in this investment offer.

Please also be advised that all Swedish material will not be translated and that the partial translations made available are to be viewed as an introduction to the Swedish offer. For the complete offer we herby refer you to the Swedish material.

 

Contact information

www.BrighterCompany.com

www.BrighterCompany.com/video

www.facebook.com/brightercompany

www.twitter.com/Brighter_AB
T: +46 8 55 00 88 20

F: +46 8 55 00 88 30

 

Truls Sjöstedt, CEO  Brighter AB (publ)

T: +46 709 73 46 00  Email: truls.sjostedt@brightercompany.com